Joshua Eizen
Fortune : 281 446 $ au 31/05/2026
Fortune : 281 446 $ au 31/05/2026
Joshua Eizen is currently Secretary, Chief Operating & Legal Officer at AN2 Therapeutics, Inc. since 2024.
Formerly, Mr. Eizen was VP & Associate General Counsel at Jazz Pharmaceuticals, Inc. from 2021 to 2022; VP & General Counsel at GW Pharmaceuticals Ltd. from 2018 to 2021; Associate Chief Counsel-Enforcement at the US Food & Drug Administration from 2008 to 2014; Chief Compliance Officer & General Counsel at Pulmonary Hypertension Association, Inc. from 2015 to 2018; Associate at McKee Nelson LLP; and Chief Compliance Officer & Senior Counsel at Actelion Pharmaceuticals US, Inc. from 2015 to 2018.
Education includes undergraduate and graduate degrees from Case Western Reserve University and a graduate degree from Georgetown University Law Center.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 64 999 ( 0,18% ) | 281 446 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Directeur des opérations | 04/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | 01/09/2022 |
| GW PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/05/2021 |
Pulmonary Hypertension Association, Inc.
Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Compliance Officer | 01/06/2018 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Compliance Officer | 01/06/2018 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/10/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
McKee Nelson LLP
McKee Nelson LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Pulmonary Hypertension Association, Inc.
Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national